CV Sciences (CVSI) Stock Price, News & Analysis

Company Overview

CV Sciences, Inc. is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation. The company sells its branded products through e-commerce channels, specialty retailers, pharmacies and major retail chains, and it holds regulatory registrations and quality certifications designed to meet evolving standards for hemp-derived products in domestic and select international markets.

Since its incorporation in Delaware in 2012, CV Sciences has expanded its geographic reach to serve customers across North America, Europe and parts of Asia, with strategic partnerships aimed at broadening distribution and ensuring supply-chain integrity. The company emphasizes scientific research, quality control and regulatory compliance, maintaining laboratory testing protocols for potency and purity at multiple stages of production.

CV Sciences is guided by a management team with experience in nutraceuticals, regulatory affairs and consumer-goods marketing. The company continues to invest in product innovation, clinical research collaborations and brand development as it seeks to strengthen its position in the growing hemp-derived CBD market.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.03 to $0.05
• 52-Week Range: $0.02 to $0.10
• Volume: 283,526 shs
• Average Volume: 631,315 shs
• Market Capitalization: $6.32 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CV Sciences Stock Analysis - MarketRank™

CV Sciences scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for CV Sciences.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

CV Sciences has a P/B Ratio of 3.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of CV Sciences has been sold short.

Short Interest Ratio / Days to Cover

CV Sciences has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CV Sciences has recently decreased by 81.32%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CV Sciences does not currently pay a dividend.

Dividend Growth

CV Sciences does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.33

News Sentiment

CV Sciences has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for CV Sciences this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, CV Sciences insiders have not sold or bought any company stock.

Percentage Held by Insiders

6.70% of the stock of CV Sciences is held by insiders.

Percentage Held by Institutions

CV Sciences has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/12/2021
• Today: 5/21/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CVSI
• Previous Symbol: NASDAQ:CVSI
• CIK: 1510964
• Web: www.cvsciences.com
• Phone: (866) 290-2157
• Fax: 619-876-4321
• Employees: 70
• Year Founded: 2016

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$960 thousand
• Net Margins: -11.15%
• Pretax Margin: -11.14%
• Return on Equity: -94.61%
• Return on Assets: -20.85%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.96
• Quick Ratio: 0.21

Sales & Book Value

• Annual Sales: $13.79 million
• Price / Sales: 0.46
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.01 per share
• Price / Book: 3.10

Miscellaneous

• Outstanding Shares: 203,980,000
• Free Float: 190,311,000
• Market Cap: $6.32 million
• Optionable: Not Optionable
• Beta: 0.45